日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析:激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms

HER2低表达乳腺癌概念的演变:基因组学见解、定义和治疗范式

Kantarjian, Hagop M; Baccarani, Michele; Jabbour, Elias; Saglio, Giuseppe; Cortes, Jorge E; Hensing, Whitney L; Podany, Emily L; Sears, James J; Tapiavala, Shaili; Davis, Andrew A

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer

转移性乳腺癌中ctDNA谱、靶向治疗使用和预后的种族差异

Podany, Emily L; Foffano, Lorenzo; Gerratana, Lorenzo; Medford, Arielle J; Clifton, Katherine; Tapiavala, Shaili; Velimirovic, Marko; Lipsyc-Sharf, Marla; Reduzzi, Carolina; Bubie, Adrian; Putur, Annika; Ademuyiwa, Foluso O; Puglisi, Fabio; Gradishar, William J; Ma, Cynthia X; Bardia, Aditya; Cristofanilli, Massimo; Davis, Andrew A

Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center

综合癌症中心不同患者参与乳腺癌临床试验

Podany, Emily L; Bulsara, Shaun; Sanchez, Katherine; Otte, Kristen; Ellis, Matthew J; Kinik, Maryam